Compagnie Lombard Odier SCmA’s Pacific Biosciences PACB Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-12,500	Closed	-$370K	–	663
2021 Q2	$437K	Buy	12,500 +10,500	+525%	+$305K	0.01%	246
2021 Q1	$67K	Buy	+2,000	New	+$70K	﹤0.01%	481
2019 Q3	–	Sell	-10,000	Closed	-$61K	–	541
2019 Q2	$61K	Hold	10,000	–	–	﹤0.01%	350
2019 Q1	$72K	Hold	10,000	–	–	﹤0.01%	378
2018 Q4	$74K	Sell	10,000 -115,000	-92%	-$729K	﹤0.01%	354
2018 Q3	$676K	Sell	125,000 -30,000	-19%	-$129K	0.02%	176
2018 Q2	$552K	Sell	155,000 -25,000	-14%	-$69.4K	0.02%	200
2018 Q1	$366K	Sell	180,000 -120,000	-40%	-$312K	0.01%	243
2017 Q4	$790K	Buy	300,000 +150,000	+100%	+$525K	0.01%	254
2017 Q3	$786K	Buy	150,000 +3,000	+2%	+$12.9K	0.03%	224
2017 Q2	$524K	Sell	147,000 -22,200	-13%	-$89.5K	0.02%	264
2017 Q1	$875K	Sell	169,200 -3,000	-2%	-$14.7K	0.03%	230
2016 Q4	$654K	Buy	172,200 +37,200	+28%	+$270K	0.02%	293
2016 Q3	$1.21M	Buy	135,000 +3,000	+2%	+$25.1K	0.04%	243
2016 Q2	$927K	Buy	132,000 +48,400	+58%	+$442K	0.03%	274
2016 Q1	$713K	Buy	83,600 +35,600	+74%	+$350K	0.02%	300
2015 Q4	$630K	Sell	48,000 -76,500	-61%	-$686K	0.02%	290
2015 Q3	$456K	Buy	124,500 +33,000	+36%	+$161K	0.02%	287
2015 Q2	$528K	Buy	91,500 +3,500	+4%	+$20.3K	0.02%	300
2015 Q1	$514K	Sell	88,000 -4,000	-4%	-$27.6K	0.02%	306
2014 Q4	$721K	Sell	92,000 -52,341	-36%	-$335K	0.03%	227
2014 Q3	$709K	Buy	144,341 +42,841	+42%	+$224K	0.03%	245
2014 Q2	$627K	Buy	101,500 +9,000	+10%	+$45K	0.02%	278
2014 Q1	$495K	Buy	+92,500	New	+$585K	0.02%	325